Fresh Tracks Therapeutics, Inc. financial data

Location
2000 Central Avenue, Suite 100, Boulder, CO
Fiscal year end
December 31
Latest financial report
10-K - Q4 2023 - Mar 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 597 % +31.3%
Return On Equity -58.8 % +65.1%
Return On Assets -49 % +62.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.97M shares +1.13%
Common Stock, Shares, Outstanding 5.97M shares +97.9%
Entity Public Float 4.1M USD -72.5%
Common Stock, Value, Issued 60K USD +100%
Weighted Average Number of Shares Outstanding, Basic 5.39M shares +92.1%
Weighted Average Number of Shares Outstanding, Diluted 5.39M shares +92.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 8.01M USD +15.3%
Research and Development Expense 3.18M USD -77.3%
General and Administrative Expense 11.2M USD -22.5%
Operating Income (Loss) -6.36M USD +70.5%
Net Income (Loss) Attributable to Parent -5.69M USD +73%
Earnings Per Share, Basic -1 USD/shares +85.9%
Earnings Per Share, Diluted -1 USD/shares +85.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.9M USD +25.2%
Other Assets, Current 7K USD -12.5%
Assets, Current 11.6M USD +14.6%
Property, Plant and Equipment, Net 34K USD -54.7%
Operating Lease, Right-of-Use Asset 0 USD -100%
Assets 11.6M USD +12.8%
Accounts Payable, Current 406K USD -28.9%
Employee-related Liabilities, Current 232K USD -82.4%
Accrued Liabilities, Current 1.25M USD -49.1%
Liabilities, Current 1.66M USD -46.2%
Retained Earnings (Accumulated Deficit) -172M USD -3.42%
Stockholders' Equity Attributable to Parent 9.93M USD +38%
Liabilities and Equity 11.6M USD +12.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.49M USD +53%
Net Cash Provided by (Used in) Financing Activities 6.57M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 5.97M shares +97.9%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.08M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.9M USD +25.2%
Deferred Tax Assets, Valuation Allowance 132M USD -0.28%
Deferred Tax Assets, Gross 132M USD -0.28%
Operating Lease, Liability 19K USD -47.2%
Depreciation 10K USD +42.9%
Lessee, Operating Lease, Liability, to be Paid 19K USD -48.6%
Operating Lease, Liability, Current 0 USD -100%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -50%
Deferred Tax Assets, Operating Loss Carryforwards 106M USD +1.72%
Additional Paid in Capital 182M USD +4.84%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 1.92M USD -11%
Interest Expense 5K USD -44.4%